Amgen Cash Flow from Investing Activities 2010-2025 | AMGN
Amgen cash flow from investing activities for the twelve months ending March 31, 2025 was $-2.571B, a 89.46% decline year-over-year.
- Amgen annual cash flow from investing activities for 2024 was $-1.046B, a 96.01% decline from 2023.
- Amgen annual cash flow from investing activities for 2023 was $-26.204B, a 333.55% increase from 2022.
- Amgen annual cash flow from investing activities for 2022 was $-6.044B, a 924.56% decline from 2021.